Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Koei Chemical is a Japan-based publicly traded specialty chemicals manufacturer that produces nitrogen-containing compounds and other chemical products, including pyridines, pyrazines, amines, formalin products, and ionic liquids. The company supplies materials used across pharmaceuticals, agrochemicals, resins, electronics, and other industrial applications, and it also supports custom synthesis and specialty-product manufacturing. Within healthcare, Koei Chemical appears to participate primarily as an upstream supplier of small-molecule intermediates and raw materials for the pharmaceutical industry rather than as a therapeutic drug developer. The company operates from Tokyo with manufacturing and research functions in Chiba and maintains additional business presence in Osaka. It has been in operation since 1917 and remains part of the Sumitomo Chemical group while listed on the Tokyo Stock Exchange.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Koei Chemical.